Cargando…

Fluvoxamine for the Early Treatment of COVID-19: A Meta-analysis of Randomized Clinical Trials

Fluvoxamine is widely prescribed as an antidepressant. Recent studies show the drug may have a clinical benefit in treating COVID-19. We aimed to perform a meta-analysis of the existing randomized trials of fluvoxamine compared with placebo on the early treatment of COVID-19 patients. We included on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Christina M., Harari, Ofir, Chernecki, Cameron, Thorlund, Kristian, Forrest, Jamie I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128689/ https://www.ncbi.nlm.nih.gov/pubmed/35263710 http://dx.doi.org/10.4269/ajtmh.21-1310

Ejemplares similares

Early Treatment with Fluvoxamine among Patients with COVID-19: A Cost-Consequence Model
por: Mills, Fergal P., et al.
Publicado: (2023)

Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial
por: Reis, Gilmar, et al.
Publicado: (2022)

Association of Early Interventions With Birth Outcomes and Child Linear Growth in Low-Income and Middle-Income Countries: Bayesian Network Meta-analyses of Randomized Clinical Trials
por: Park, Jay J. H., et al.
Publicado: (2019)

Fluvoxamine
por: DeVane, C Lindsay
Publicado: (2005)

Effects of biomarker diagnostic accuracy on biomarker-guided phase 2 trials
por: Park, Jay JH., et al.
Publicado: (2019)

Fluvoxamine in the treatment of anxiety disorders
por: Irons, Jane
Publicado: (2005)

Fluvoxamine for the treatment of COVID-19
por: Dodds, Michael G, et al.
Publicado: (2022)

Fluvoxamine for the treatment of COVID-19
por: Boulware, David R, et al.
Publicado: (2022)

Fluvoxamine for the treatment of COVID-19
por: Kim, Hyun, et al.
Publicado: (2022)

Fluvoxamine for the treatment of COVID-19
por: Marzolini, Catia, et al.
Publicado: (2022)

A real-time dashboard of clinical trials for COVID-19
por: Thorlund, Kristian, et al.
Publicado: (2020)

Prospective Cohort of Fluvoxamine for Early Treatment of Coronavirus Disease 19
por: Seftel, David, et al.
Publicado: (2021)

Comparison of Saffron and Fluvoxamine in the Treatment of Mild to Moderate Obsessive-Compulsive Disorder: A Double Blind Randomized Clinical Trial
por: Esalatmanesh, Sophia, et al.
Publicado: (2017)

The importance of appropriate selection of clinical endpoints in outpatient COVID-19 clinical trials
por: Thorlund, Kristian, et al.
Publicado: (2023)

Fluvoxamine for the treatment of COVID-19 – Author's reply
por: Reis, Gilmar, et al.
Publicado: (2022)

Fluvoxamine, melatonin and COVID-19
por: Anderson, George M.
Publicado: (2021)

Bayesian adaptive clinical trials of combination treatments
por: Thorlund, Kristian, et al.
Publicado: (2017)

Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols
por: Park, Jay J. H, et al.
Publicado: (2019)

Effect of Fluvoxamine on Interleukin-6 Levels in COVID-19 Patients Hospitalized in ICU: A Randomized Clinical Trial
por: Safa, Mitra, et al.
Publicado: (2022)

Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Reporting and design of randomized controlled trials for COVID-19: A systematic review
por: Dillman, Alison, et al.
Publicado: (2021)

Fluvoxamine Treatment of Patients with Symptomatic COVID-19 in a Community Treatment Center: A Preliminary Result of Randomized Controlled Trial
por: Seo, Hyeonji, et al.
Publicado: (2022)

Trial Sequential Analysis and Updated Meta-Analysis of Fluvoxamine on Clinical Deterioration in Adult Patients with Symptomatic COVID-19 Infection
por: Yu, Chia-Ling, et al.
Publicado: (2023)

Tolerability and safety of fluvoxamine and other antidepressants
por: Westenberg, HGM, et al.
Publicado: (2006)

Fluvoxamine alleviates paclitaxel-induced neurotoxicity
por: Tanimukai, Hitoshi, et al.
Publicado: (2015)

Fluvoxamine for symptomatic outpatients with COVID-19
por: Wu, Peter E., et al.
Publicado: (2022)

Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence
por: Facente, Shelley N., et al.
Publicado: (2021)

Efficacy and safety of fluvoxamine for the treatment of COVID-19 patients: A systematic review and meta-analysis
por: Cheema, Huzaifa Ahmad, et al.
Publicado: (2022)

Pilot study of fluvoxamine treatment for climacteric symptoms in Japanese women
por: Oishi, Akira, et al.
Publicado: (2007)

Emergence of kleptomania during treatment for obsessive compulsive disorder with fluvoxamine
por: Gupta, Parveen Rani
Publicado: (2014)

Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID-19
por: Mahdi, Mohamed, et al.
Publicado: (2022)

Reply: Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19
por: Seo, Hyeonji, et al.
Publicado: (2022)

Erratum: Fluvoxamine Treatment of Patients with Symptomatic COVID-19 in a Community Treatment Center: A Preliminary Result of Randomized Controlled Trial
Publicado: (2022)

Interventions to improve birth outcomes of pregnant women living in low- and middle-income countries: a systematic review and network meta-analysis
por: Park, Jay J. H., et al.
Publicado: (2020)

Incorporating alternative design clinical trials in network meta-analyses
por: Thorlund, Kristian, et al.
Publicado: (2014)

Efficacy and tolerability of fluvoxamine in adults with social anxiety disorder: A meta-analysis
por: Liu, Xue, et al.
Publicado: (2018)

Stability of additive treatment effects in multiple treatment comparison meta-analysis: a simulation study
por: Thorlund, Kristian, et al.
Publicado: (2012)

Comment on: “Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence”
por: Mazza, Mario Gennaro, et al.
Publicado: (2022)

Interventions to improve linear growth during complementary feeding period for children aged 6-24 months living in low- and middle-income countries: a systematic review and network meta-analysis
por: Park, Jay J. H., et al.
Publicado: (2020)

Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19: The TOGETHER Randomized Clinical Trial
por: Reis, Gilmar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e67md40irhrc1k7rujaicmgcbj